Gene · 341
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cerebrospinal Fluid Proteomic Profiles in Patients with Postherpetic Neuralgia. | J Proteome Res | 2023 | 37966014 | PubTator, text mining | PubMed |
| Metabolic predictors of response to immune checkpoint blockade therapy. | iScience | 2023 | 37965137 | PubTator, text mining | PubMed |
| Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease. | EMBO J | 2023 | 37962490 | PubTator, text mining | PubMed |
| Proteomic Determinants of Variation in Cholesterol Efflux: Observations from the Dallas Heart Study. | Int J Mol Sci | 2023 | 37958510 | PubTator, text mining | PubMed |
| Cognitive impairment in long-living adults: a genome-wide association study, polygenic risk score model and molecular modeling of the APOE protein. | Front Aging Neurosci | 2023 | 37953886 | PubTator, text mining | PubMed |
| Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications. | Front Immunol | 2023 | 37942325 | PubTator, text mining | PubMed |
| Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma. | Nat Commun | 2023 | 37932266 | PubTator, text mining | PubMed |
| Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. | EBioMedicine | 2023 | 37924708 | PubTator, text mining | PubMed |
| High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine. | Front Cardiovasc Med | 2023 | 37908502 | PubTator, text mining | PubMed |
| In-organoid single-cell CRISPR screening reveals determinants of hepatocyte differentiation and maturation. | Genome Biol | 2023 | 37907970 | PubTator, text mining | PubMed |
| Integration of multiple-omics data to reveal the shared genetic architecture of educational attainment, intelligence, cognitive performance, and Alzheimer's disease. | Front Genet | 2023 | 37900179 | PubTator, text mining | PubMed |
| Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability. | Int J Mol Sci | 2023 | 37894856 | PubTator, text mining | PubMed |
| Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37894344 | PubTator, text mining | PubMed |
| Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease. | Biomedicines | 2023 | 37893070 | PubTator, text mining | PubMed |
| Using LLMs and Explainable ML to Analyze Biomarkers at Single-Cell Level for Improved Understanding of Diseases. | Biomolecules | 2023 | 37892198 | PubTator, text mining | PubMed |
| Pediatric Patients with Sitosterolemia: Next-Generation Sequencing and Biochemical Examination in Clinical Practice. | J Pers Med | 2023 | 37888103 | PubTator, text mining | PubMed |
| Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond. | Cells | 2023 | 37887295 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals neurovascular-osteochondral network crosstalk during temporomandibular joint osteoarthritis: Pilot study in a human condylar cartilage. | Heliyon | 2023 | 37867837 | PubTator, text mining | PubMed |
| Beyond apples and pears: sex-specific genetics of body fat percentage. | Front Endocrinol (Lausanne) | 2023 | 37867527 | PubTator, text mining | PubMed |
| The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease. | Eur Cardiol | 2023 | 37860700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/341/papers?page=15